Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2016)

Viridian Therapeutics, Inc.\DE (VRDN) has 1 years of Current Leases data on record, last reported at $80000.0 in Q4 2014.

  • For Q4 2014, Current Leases changed N/A year-over-year to $80000.0; the TTM value through Dec 2014 reached $80000.0, changed N/A, while the annual FY2014 figure was $80000.0, N/A changed from the prior year.
  • Current Leases reached $80000.0 in Q4 2014 per VRDN's latest filing.
  • Across five years, Current Leases topped out at $80000.0 in Q4 2014 and bottomed at $80000.0 in Q4 2014.